Cover Image
市場調查報告書

產前檢查市場動向

Advancements in Prenatal Screening Trends

出版商 Global Industry Analysts, Inc. 商品編碼 297791
出版日期 內容資訊 英文 33 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
產前檢查市場動向 Advancements in Prenatal Screening Trends
出版日期: 2014年01月01日 內容資訊: 英文 33 Pages
簡介

本報告針對世界產前檢查市場動向進行調查分析,包括非侵入產前篩檢、非侵入產前檢查、美國非侵入產前篩檢市場概要考察、醫師與諮詢師的角色,目錄介紹如下。

第1章 產前篩檢發展報告

  • 產前診斷:介紹

第2章 市場情報

  • 確認成長的產前篩檢市場
  • 非侵入產前篩檢新發展
  • 非侵入產前檢查新發展
  • 美國非侵入產前篩檢市場新動向
  • 產前診斷選擇
  • 產前診斷市場新發展
  • 分子診斷市場新動向
  • 中國產前檢查市場新動向

第3章 產前診斷概要

  • 篩檢檢查VS診斷檢查
  • 產前診斷目的
  • 產前診斷檢查出的疾病
  • 產前篩檢效果
  • 陰性篩檢VS陽性篩檢
  • 孕婦重大醫療資料
  • 神經管(NT)異常與染色體異常
  • 其他胎兒異常
  • 代表性的產前診斷循環
  • 早孕期綜合篩查(FTS):技術與成果
  • 第2孕期綜合篩查:技術與成果
  • 定期超音波檢查:技術與成果
  • 產前血液綜合檢查(SIPS):技術與成果
  • 產前綜合檢查(IPS):技術與成果
  • 產前篩檢結果基礎後續活動

第4章 產前篩檢:指南與程序

第5章 產前篩檢技術新發展

第6章 主要市場參加者

第7章 企業內部創業

第8章 產品發售/技術革新

第9章 附錄

目錄
Product Code: 141061

The report illustrates the advancements in Prenatal Screening with a brief note on emerging developments in non-invasive prenatal screening, emerging developments in non-invasive prenatal testing, and emerging trends in the US non-invasive prenatal screening market. Prenatal diagnosis enables detection of chromosomal abnormalities and genetic mutations in human fetus, or embryo, at very early stage of pregnancy, including chromosome anomalies, neural tube defects, genetic abnormalities, Down's syndrome (trisomy 21 condition), and other conditions. In addition the report also highlights the role of the obstetricians, physicians and genetic counselors in helping the expectant mothers to arrive at an informed decision concerning prenatal screening.

Table of Contents

1. ADVANCEMENTS IN PRENATAL SCREENING - A FOCUS REPORT

  • Prenatal Diagnosis - A Prelude

2. MARKET INFORMATION

  • Prenatal Screening Market Poised for Growth
  • Emerging Developments in Non-Invasive Prenatal Screening
  • Emerging Developments in Non-Invasive Prenatal Testing
  • Emerging Trends in the US Non-Invasive Prenatal Screening Market
  • Options Available for Prenatal Diagnostics
  • Emerging Developments in Prenatal Diagnostics Market
  • Emerging Trends in Molecular Diagnostics Market
  • Emerging Trends in Chinese Prenatal Testing Market

3. PRENATAL DIAGNOSIS - AN OVERVIEW

  • Screening Test vis-a-vis Diagnostic Test
  • Purpose of Prenatal Diagnosis
  • Conditions Specifically Tested for During Prenatal Diagnosis
  • Efficacy of Prenatal Screening
  • Negative Versus Positive Screens
  • Health Information Critical for Expectant Mothers
  • Neural Tube (NT) Abnormality and Chromosomal Anomaly
  • Other Fetal Disorders
    • Spinal Cord Abnormalities
    • Placental Abnormalities
    • Anatomy Abnormalities
  • A Typical Prenatal Diagnosis Cycle
  • First Trimester Combined Screening (FTS) - Technologies & Outcomes
  • Second Trimester Combined Test - Technologies & Outcomes
  • Routine Ultrasound - Technologies & Outcomes
  • Serum Integrated Prenatal Screen (SIPS) - Technology & Outcomes
  • Integrated Prenatal Screen (IPS) - Technology & Outcomes
  • Follow-up Action Based on Outcomes of Prenatal Screening

4. PRENATAL SCREENING - GUIDELINES & PROCEDURES

  • Prenatal Testing Decisions - Role of Physicians and Genetic Counselors
  • Testing Procedures for Prenatal Diagnosis
  • Maternal Serum Screening Cornerstone for Prenatal Diagnosis
  • Triple Tests and Quadruple Screen
  • Fetal Aneuploidy Screening
  • Procedures for Screening Fetal DNA
  • Amniocentesis
  • Chorionic Villus Sampling (CVS)
  • NT Ultrasound Scan
  • Morphology Ultrasound Scan
  • Genome-Wide Techniques
  • Efficacy of Blood Tests
  • Developments in Prenatal Diagnosis
  • Efficacy of Prenatal Diagnosis Techniques

5. EMERGING DEVELOPMENTS IN PRENATAL SCREENING TECHNOLOGIES

  • Emerging Screening Technologies
  • Prenatal Screening for Trisomy 21 Condition
  • Maternal Blood Sampling
  • Fetal DNA - Abnormality Testing
  • Genetic Profiling for Family Planning
  • Developments in Nasal Bone Analysis
  • Nasal Bone Sonography
  • Advances in Multiplex Fluorescent PCR
  • Development in Prenatal Screening for CF
  • Emerging Developments in Identification of Fetal Aneuploidy
  • Doppler Ultrasound of Ductus Venosus
  • Integrated First Trimester and Second Trimester Screening for Aneuploidy
  • Advancements in High-Speed MRI for Diagnosing Fetal Congenital Disorders
  • Advancements in 3D Ultrasound
  • Other Developments in Prenatal Screening
  • Technologies for Measuring DNA and Fetal Cells
  • Doppler Ultrasound for Noninvasive Screening of Fetal Anemia

6. NOTEWORTHY MARKET PARTICIPANTS

  • Ariosa Diagnostics, Inc. (USA)
  • Natera, Inc. (USA)
  • PerkinElmer, Inc. (USA)

7. CORPORATE INITIATIVES

  • BGI Pens an Agreement with GENNET
  • Illumina Takes Over BlueGnome

8. PRODUCT LAUNCHES/TECHNOLOGY INNOVATIONS

  • LABCO Introduces NIPD Test in Spain
  • LifeCodexx Unveils PraenaTest Service
  • University of Washington Launches Innovative NIPD Test
  • Ariosa Diagnostics Launches Launch Harmony
  • CUHK Launches safeT21
  • GSN Introduces Parental Support

9. APPENDIX

Back to Top